Shanghai MicroPort's Total Knee System Obtains CE Mark in Europe
08:15 PM EST, 12/05/2022 (MT Newswires) -- Shanghai MicroPort MedBot (Group)'s (HKG:2252) SkyWalker Total Knee System obtained the CE Mark in Europe, according to a filing on Monday. The move makes Sk
Minimally invasive Robot-B: mid-term report 2022
Shanghai MicroPort MedBot Widens Loss in H1
01:51 AM EDT, 08/29/2022 (MT Newswires) -- Shanghai MicroPort MedBot (HKG:2252) said its loss attributable to the shareholders widened to 459.1 million yuan ($66.4 million) in the first half of 2022 f
Minimally invasive Robot-B: interim results announcement for the six months ended June 30, 2022
Minimally invasive Robot-B: date of Board meeting
Shanghai MicroPort MedBot's Surgical Robot Gets US FDA Approval; Shares Down 5%
11:08 PM EDT, 07/11/2022 (MT Newswires) -- Shanghai MicroPort MedBot (HKG:2252) obtained clearance from the US Food and Drug Administration for its Honghu orthopedic surgical robot, according to a Mon
MicroPort MedBot Shareholders to Vote June 21 on $420 Million Shanghai IPO Proposal
03:55 AM EDT, 06/02/2022 (MT Newswires) -- Shareholders of MicroPort MedBot Group (HKG:2252) will meet on June 21 to vote on the company's proposed secondary listing in Shanghai. The surgical robot m
MicroPort Completes Patient Enrollment for China Registrational Study of Surgical Robot
03:40 AM EDT, 05/27/2022 (MT Newswires) -- Shanghai MicroPort MedBot Group (HKG:2252) completed enrolling patients for its registrational clinical trials in China of R-ONE, according to a Friday discl
We Think Shanghai MicroPort MedBot (Group) (HKG:2252) Can Afford To Drive Business Growth
We can readily understand why investors are attracted to unprofitable companies. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring rev
Minimally invasive Robot-BRV 2021 Annual report
Loading...
No Stock Yet